心通醫療-B(02160.HK)獲控股股東增持1196.4萬股
格隆匯4月10日丨心通醫療-B(02160.HK)公佈,公司董事會已獲公司控股股東微創醫療科學有限公司吿知,自2022年4月6日至4月8日,Shanghai MicroPort Limited(微創醫療科學有限公司的全資子公司,及公司控股股東)按平均價每股約2.8723港元,於公開市場購入合共1196.4萬股公司股份。
緊接購股事項後,Shanghai MicroPort Limited持有10.9億股股份,佔於本公吿日期公司全部已發行股本約45.37%。
誠如微創醫療科學有限公司所吿知,其對公司的增長、發展和未來前景充滿信心,並可能在適當時候於遵守適用法律法規的情況下進一步增加其在公司股份中的權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.